Adrenomedullin: A Tumor Progression Factor via Angiogenic Control

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|6|7|635-643

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.6, Iss.7, 2006-11, pp. : 635-643

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Angiogenic and Anti-Tumor Properties of Proteasome Inhibitors

By  

Current Cancer Drug Targets, Vol. 5, Iss. 7, 2005-11 ,pp. : 529-541

Bentham Science Publishers

Access to resources Recommend Favorite

Substance P induces tumor necrosis factor- release from human skin via mitogen-activated protein kinase

By Okabe T.   Hide M.   Koro O.   Yamamoto S.  

European Journal of Pharmacology, Vol. 398, Iss. 2, 2000-06 ,pp. : 309-315

Elsevier

Access to resources Recommend Favorite

VEGF in Tumor Progression and Targeted Therapy

By  

Current Cancer Drug Targets, Vol. 13, Iss. 4, 2013-05 ,pp. : 423-443

Bentham Science Publishers

Access to resources Recommend Favorite

Family and case–control association study of the tumor necrosis factor-alpha (TNF-α) gene with schizophrenia and response to antipsychotic medication

By Zai Gwyneth   Müller Daniel   Volavka Jan   Czobor Pal   Lieberman Jeffrey   Meltzer Herbert   Kennedy James  

Psychopharmacology, Vol. 188, Iss. 2, 2006-10 ,pp. : 171-182

Springer Publishing Company

Access to resources Recommend Favorite

Radiolabeled Tracers for Imaging of Tumor Angiogenesis and Evaluation of Anti-Angiogenic Therapies

By  

Current Pharmaceutical Design, Vol. 10, Iss. 13, 2004-05 ,pp. : 1439-1455

Bentham Science Publishers

Access to resources Recommend Favorite